Xilio Therapeutics, Inc. Investing Cash Flow
Xilio Therapeutics, Inc. (XLO) reported Investing Cash Flow of -$575.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-12
- Xilio Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$19.00K.
- Xilio Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$556.00K.
- Xilio Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$95.00K.
- Xilio Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $0.00.
- Xilio Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$518.00K.
- Xilio Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$36.00K.
- Xilio Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$486.00K.
- Xilio Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$1.87M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$575.00K 10-Q · filed 2026-08-12 | -$670.00K derived: sum of 3 quarters · filed 2026-08-12 | -$670.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$556.00K 10-Q · filed 2026-05-12 | -$651.00K derived: sum of 2 quarters · filed 2026-05-12 | -$651.00K derived: sum of 3 quarters · filed 2026-05-12 | -$1.05M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | -$95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$95.00K derived: sum of 2 quarters · filed 2026-03-23 | -$496.00K derived: sum of 3 quarters · filed 2026-08-12 | -$518.00K 10-K · filed 2026-03-23 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$401.00K derived: sum of 2 quarters · filed 2026-08-12 | -$423.00K 10-Q · filed 2025-11-13 | -$429.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$401.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$423.00K 10-Q · filed 2026-08-12 | -$429.00K derived: sum of 3 quarters · filed 2026-08-12 | -$438.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$22.00K 10-Q · filed 2026-05-12 | -$28.00K derived: sum of 2 quarters · filed 2026-05-12 | -$37.00K derived: sum of 3 quarters · filed 2026-05-12 | |
| 2024-12-31 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$15.00K derived: sum of 2 quarters · filed 2026-03-23 | -$36.00K 10-K · filed 2026-03-23 | |
| 2024-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$30.00K 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | -$21.00K 10-Q · filed 2025-08-14 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $0.00 derived: sum of 2 quarters · filed 2025-03-11 | -$316.00K derived: sum of 3 quarters · filed 2025-03-11 | -$486.00K 10-K · filed 2025-03-11 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$316.00K derived: sum of 2 quarters · filed 2024-11-07 | -$486.00K 10-Q · filed 2024-11-07 | -$995.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$316.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$486.00K 10-Q · filed 2024-08-08 | -$995.00K derived: sum of 3 quarters · filed 2024-08-08 | -$1.33M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$170.00K 10-Q · filed 2024-05-14 | -$679.00K derived: sum of 2 quarters · filed 2024-05-14 | -$1.01M derived: sum of 3 quarters · filed 2024-05-14 | -$1.78M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$509.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$842.00K derived: sum of 2 quarters · filed 2024-04-01 | -$1.61M derived: sum of 3 quarters · filed 2024-04-01 | -$1.87M 10-K · filed 2024-04-01 |
| 2022-09-30 | -$333.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$1.10M derived: sum of 2 quarters · filed 2023-11-09 | -$1.36M 10-Q · filed 2023-11-09 | -$1.74M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$771.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$1.02M 10-Q · filed 2023-08-14 | -$1.40M derived: sum of 3 quarters · filed 2023-08-14 | -$1.52M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$254.00K 10-Q · filed 2023-05-09 | -$632.00K derived: sum of 2 quarters · filed 2023-05-09 | -$746.00K derived: sum of 3 quarters · filed 2023-05-09 | -$1.18M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$378.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$492.00K derived: sum of 2 quarters · filed 2023-03-02 | -$930.00K derived: sum of 3 quarters · filed 2023-03-02 | -$1.10M 10-K · filed 2023-03-02 |
| 2021-09-30 | -$114.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$552.00K derived: sum of 2 quarters · filed 2022-11-09 | -$722.00K 10-Q · filed 2022-11-09 | -$830.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$438.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$608.00K 10-Q · filed 2022-08-09 | -$716.00K derived: sum of 3 quarters · filed 2022-08-09 | |
| 2021-03-31 | -$170.00K 10-Q · filed 2022-05-12 | -$278.00K derived: sum of 2 quarters · filed 2022-05-12 | ||
| 2020-12-31 | -$108.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$2.19M 10-K · filed 2022-03-01 | ||
| 2020-09-30 | -$2.08M 10-Q · filed 2021-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 |